Clinical Trials Logo

Clinical Trial Summary

To determine the time to and rate of hematologic engraftment following unrelated umbilical cord blood transplantation in adults with one or two cord blood units using total body irradiation and fludarabine as the transplant conditioning regimen and cyclosporine/MMF as graft-versus-host disease prophylaxis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00897260
Study type Interventional
Source University of British Columbia
Contact
Status Completed
Phase N/A
Start date May 2009
Completion date January 9, 2013

See also
  Status Clinical Trial Phase
Completed NCT04932967 - Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Not yet recruiting NCT02900768 - Effects of Exercise on Allogeneic Stem Cell Transplant N/A
Recruiting NCT04082910 - Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells Phase 1/Phase 2
Recruiting NCT05510089 - Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies N/A
Terminated NCT04093622 - Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
Recruiting NCT06225856 - An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies Phase 1
Recruiting NCT06106360 - A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
Recruiting NCT02828462 - Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
Completed NCT01714180 - Effect of Body Mass on Acyclovir Pharmacokinetics N/A
Completed NCT03241550 - A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients Phase 1
Active, not recruiting NCT04684108 - SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies Phase 1
Completed NCT02598752 - Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed NCT02880709 - The Effect of Special Diets in Hematological Cancer Patients Phase 4
Completed NCT00894049 - A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation Phase 2
Completed NCT04687982 - Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). N/A
Recruiting NCT03850366 - HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Phase 2
Not yet recruiting NCT06066255 - PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM Phase 2
Enrolling by invitation NCT05364359 - Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy N/A
Recruiting NCT04841447 - Membrane Target Detection for Leukemia Treatment
Not yet recruiting NCT06224452 - Is Ibrutinib-related Atrial Fibrillation Dose Dependent